Evidence map›Paper›PMID 42311438›Full record

ArticleFrontiers in digital health2026

Explainable and interpretable models for predicting early-onset hypertension in the Tlalpan 2020 cohort.

Guadalupe Gutiérrez-Esparza, Mireya Martínez-García, Luis M Amezcua-Guerra, Martín Montes Rivera, Enrique Hernández-Lemus

Abstract read
In one paragraph

Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guadalupe Gutiérrez-Esparza"Researcher for Mexico" Program, Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Mexico City, Mexico.
Mireya Martínez-GarcíaDepartment of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Luis M Amezcua-GuerraDepartment of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Martín Montes RiveraResearch and postgraduate studies department, Universidad Politécnica de Aguascalientes, Aguascalientes, Ags., Mexico.
Enrique Hernández-LemusComputational Genomics Division, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Early-onset hypertension results from complex interactions among demographic, lifestyle, metabolic, and psychosocial factors. While machine learning models can predict hypertension with relative accuracy, their lack of interpretability limits their clinical utility. Methods: Using a nested case-control design based on the Tlalpan 2020 prospective cohort, a 10-year study of clinically healthy adults in Mexico City, this study applies DSRegPSOP, a symbolic regression approach, to develop interpretable mathematical models. The dataset included demographic, clinical, biochemical, lifestyle, and sleep-related variables. We addressed class imbalance using oversampling and SMOTE-based strategies, and evaluated model performance with accuracy, sensitivity, specificity, F1-score, and AUC-ROC. Results: DSRegPSOP produced compact analytical expressions with predictive performance comparable to state-of-the-art machine learning algorithms while preserving interpretability. The resulting models reveal clinically meaningful predictors of early-onset hypertension. Conclusion: DSRegPSOP provides a transparent and interpretable model for hypertension risk assessment that shows promising potential to support early prevention strategies, pending external validation on independent cohorts.

Indexed as

anxietyenergy drink consumptionfamily historyfoods consumptionhigh-fathypertensionparticle swarm optimization programmingsedentary lifestyle

Identifiers

PMID42311438
PMCPMC13268902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.